A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2006
11/29/2006	EP1088066B1 Antisense oligonucleotide constructs based on beta-arabinofuranose and its analogues
11/29/2006	EP1076053B1 3-arylphenyl sulfide derivatives and insecticides and miticides
11/29/2006	EP1043995B1 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
11/29/2006	EP1032559B1 Aminoalkylphenol derivatives for treating depression and memory dysfunction
11/29/2006	EP1026246B1 Avian infectious herpesvirus recombinants and recombinant vaccines prepared with the use of the same
11/29/2006	EP1024792B1 Topical antifungal composition
11/29/2006	EP1021406B1 Novel anandamide amidase inhibitors as analgesic agents
11/29/2006	EP1012281B1 Human leukocyte calcium activated potassium channel polypeptide
11/29/2006	EP0918848B1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
11/29/2006	EP0864648B1 Method for screening compounds regulating the expression of human-inducible nitric oxide synthase
11/29/2006	EP0789568B1 Antineoplastic cocoa extracts, methods for making, using
11/29/2006	EP0785716B1 Cytokine designated lerk-6
11/29/2006	EP0738149B1 1-aminoindan derivatives and compositions thereof
11/29/2006	EP0699194B1 5-ht4 receptor antagonists
11/29/2006	EP0631505B2 Use of a peptide
11/29/2006	EP0556292B2 Hepatitis c virus asialoglycoproteins
11/29/2006	CN1871516A Combining identifying method of labeled bridged dipiperidine
11/29/2006	CN1871351A Novel fungal proteins and nucleic acids encoding same
11/29/2006	CN1871350A Nucleic acids useful for triggering tumor cell lethality
11/29/2006	CN1871341A Methods for enhancing embryo viability
11/29/2006	CN1871251A Novel triterpene derivatives, preparation thereof and use thereof
11/29/2006	CN1871250A Nucleoside compounds for treating viral infections
11/29/2006	CN1871249A Thermally stable crystalline epirubicin hydrochloride and method of making the same
11/29/2006	CN1871248A Novel sulfenamide oxides
11/29/2006	CN1871247A Novel sulfenamides
11/29/2006	CN1871246A Methods for the preparation of {2-[(8,9)-dioxo-2,6-diaza-bicyclo[5.2.0]-non-1(7)-en-2-yl[ethyl} phosphonic acid and esters thereof
11/29/2006	CN1871244A Thiazolopyridine derivatives as adenosine receptor ligands
11/29/2006	CN1871243A Oral neurotherapeutic cefazolin compositions
11/29/2006	CN1871242A 3-(4-aminophenyl) thienopyrimid-4-one derivatives as MCH R1 antagonists for the treatment of obesity, diabetes, depression and anxiety
11/29/2006	CN1871241A Spirofuropyridine aryl derivatives
11/29/2006	CN1871240A Pyrrolopyrimidine thion derivatives
11/29/2006	CN1871239A Modulation of beta-catenin/tcf-activated transcription
11/29/2006	CN1871238A Triaza-spiropiperidine derivatives for use as GLYT-1 inhibitors in the treatment of neurological and neuropsychiatric disorders
11/29/2006	CN1871237A 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-IV inhibitors
11/29/2006	CN1871236A Novel tetraydrospiro(piperdine-2,7'- pyrrolo{3,2-b}pyridine derivatives and novel in-dole derivatives useful in the treatment of 5-ht6 receptor-related disorders
11/29/2006	CN1871235A Azabicyclic-substituted fused heteroaryl compounds for the treatment of disease
11/29/2006	CN1871234A 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible no-synthase
11/29/2006	CN1871232A Benzimidazolyl derivatives
11/29/2006	CN1871231A 吡嗪衍生物及其医药用途 Pyrazine derivatives and pharmaceutical use
11/29/2006	CN1871227A Antitumoral agent
11/29/2006	CN1871226A Dihydrobenzofuranyl alkanamines and pharmaceutical compositions containing them
11/29/2006	CN1871225A Preferentially substituted calcium channel blockers
11/29/2006	CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
11/29/2006	CN1871222A Ccr3受体拮抗剂 Ccr3 receptor antagonists
11/29/2006	CN1871217A Bengamide derivatives, method for the production thereof and use thereof for the treatment of cancer
11/29/2006	CN1871216A Inhibitors of cathepsin s
11/29/2006	CN1871215A Cyclic derivatives as modulators of chemokine receptor activity
11/29/2006	CN1871030A Method of inhibiting secretase activity
11/29/2006	CN1871029A Drug containing chymase inhibitor as the active ingredient
11/29/2006	CN1871021A Treating or preventing restless legs syndrome using prodrugs of GABA analogs
11/29/2006	CN1871016A Homogeneous, thermoreversible gel film delivery systems containing kappa-2 carrageenan
11/29/2006	CN1871015A Immunemodulating oligosaccharides
11/29/2006	CN1871014A Pharmaceutical composition containing prostaglandin
11/29/2006	CN1871013A Benzazepine derivatives as MAO-B inhibitors
11/29/2006	CN1871012A 7 and 8 membered heterocyclic cyclopentyl benzylamide modulators of chemokine receptor activity
11/29/2006	CN1871011A Use of BH4 for the treatment of respiratory diseases
11/29/2006	CN1871010A Prophylaxis and/or treatment of portal hypertension
11/29/2006	CN1871009A 5-arylpyrimidines as anticancer agents
11/29/2006	CN1871008A Triazolo-pyridazine compounds and derivatives thereof useful in the treatment of neuropathic pain
11/29/2006	CN1871007A Process for making sterile aripiprazole of desired mean particle size
11/29/2006	CN1871006A Personal care composition containing a detersive surfactant, an antidandruff component, and ketoamide surfactants
11/29/2006	CN1871005A 21-heterocyclic-4-azasteroid derivatives as androgen receptor modulators
11/29/2006	CN1871004A The use of ifenprodril in the treatment of pain
11/29/2006	CN1871003A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/29/2006	CN1871002A Alkynes II
11/29/2006	CN1871001A Alkynes III
11/29/2006	CN1871000A Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pain
11/29/2006	CN1870999A Alkynes I
11/29/2006	CN1870998A Ccr－2拮抗剂盐 Ccr-2 antagonist salt
11/29/2006	CN1870997A Treatment agent for keratoconjunctival disorder
11/29/2006	CN1870996A N-thiazol-2-yl-benzamide derivatives
11/29/2006	CN1870995A Cancer treatment with epothilones
11/29/2006	CN1870994A Multiple active agents such as anthelmintics sustained release delivery
11/29/2006	CN1870993A Pharmaceutical compositions based on idazoxan salt or one of the polymorphs thereof
11/29/2006	CN1870992A 动物饲料组合物 Animal feed compositions
11/29/2006	CN1870991A Substituted indoles as inhibitors of poly (ADP-ribose) polymerase (PARP)
11/29/2006	CN1870990A Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
11/29/2006	CN1870989A Coumarin derivative for treatment of ophthalmic disorders
11/29/2006	CN1870988A 2-azetidinones as anti-hypercholesterolemic agents
11/29/2006	CN1870987A Method for preparing submicron particles of antineoplastic agents
11/29/2006	CN1870986A Insulin secretion potentiator
11/29/2006	CN1870985A Methods of treating cancer with HDAC inhibitors
11/29/2006	CN1870984A Use of 1-aminocyclohexane derivatives to modify deposition of fibrillogenic a-beta peptides in amyloidopathies
11/29/2006	CN1870983A Compositions and foods for improving lipid metabolism
11/29/2006	CN1870982A Composition containing reduced coenzyme q
11/29/2006	CN1870981A Compositions for conjugated estrogens and associated methods
11/29/2006	CN1870980A Controlled release sterile injectable aripiprazole formulation and method
11/29/2006	CN1870979A Process for production of essentially solvent-free small particles
11/29/2006	CN1870978A Spray drying processes for forming solid amorphous dispersions of drugs and polymers
11/29/2006	CN1870977A Medicinal targeted local lipolysis
11/29/2006	CN1870976A Pharmaceutical compositions
11/29/2006	CN1870975A Oral microemulsion composition comprising biphenyldimethyldicarboxylate and silybin
11/29/2006	CN1870974A Method for producing injectable gabapentin compositions
11/29/2006	CN1870955A Kavalactone compositions and methods of use
11/29/2006	CN1870910A Synbiotic composition for infants
11/29/2006	CN1870896A Hydroxy pyridopyrrolopyrazine dione compounds useful as HIV integrase inhibitors
11/29/2006	CN1869683A Fingerprint atlas quality investigating method of ginkgo lactone material
11/29/2006	CN1869086A Copolymers, method for the production thereof, and use thereof as binders
11/29/2006	CN1869080A Novel inverse latices of copolymers of amps and of n,n-dimethylacrylamide; cosmetic use
11/29/2006	CN1869061A Peptidomimetic protease inhibitors

1 ... 3989 3990 3991 3992 3993 3994 3995 3996 3997 3998 3999 4000 4001 4002 4003 4004 4005 4006 4007 4008 4009 ... 7860